Atlas Trials

Safety and Efficacy of PD-1 Inhibitors in Patients With Liver Transplant

Clinical trial NCT03966209 · UNKNOWN

Trial details

NCT number
NCT03966209
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular CarcinomaLiver Transplantation
Start date
2019-05-01
Primary completion
2021-04-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.